FindTrial
Sign In

Steroid versus non-steroid medicines in cases of long term pulmonary diseases

To compare the efficacy and safety of dry powder inhaler of formoterol/glycopyrronium with dry powder inhaler of formoterol/budesonide in fixed dose combination in patients of chronic obstructive pulmonary disease(COPD).

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/07/014788
Enrollment
160
Registered
2018-07-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- chronic obstructive pulmonary disease

Interventions

None listed

Sponsors

Department of Pharmacology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age >19years Baseline fev1 70% Signed and dated written informed consent obtained prior to participation

Exclusion criteria

Exclusion criteria: known case of respiratory disierder other than COPD known case of significant inflammatory disease other than COPD known to be severely alpha 1 antitrypsin deficient known hypersensitivity to study medication or components having undergone lung surgery having or have had malignancy in last 5 years serious uncontrolled disease likely to interfere with the study pregnant and lactating females known case of HIV or HbsAG or Anti HCV positivity immunocompromised with severe cardiovascular disease

Design outcomes

Primary

MeasureTime frame
pulmonary function testTimepoint: 6 months—

Secondary

MeasureTime frame
safety and cost effectivenessTimepoint: 6 months—

Countries

India

Contacts

Public ContactAriba Ali Sabzposh

Jawahar Lal Nehru Medical College

naseer_bettiah@yahoo.co.in7983095011

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026